Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,092.35
(
-0.64%
)
US TECH 100
26,041.24
(
-0.62%
)
Dow Jones
49,135.81
(
-0.72%
)
Brent Oil
101.52
(
4.96%
)
Bitcoin
77,090.23
(
-1.47%
)
News Focus
News Focus

Replies to post #18510 on CytoSorbents Corporation (CTSO)

Replies to #18510 on CytoSorbents Corporation (CTSO)
icon url

hemopure36

01/07/20 11:25 AM

#18513 RE: eskay1954 #18510

I don't think so. They're the same. The link gives the same reason for suspending/pausing the trial as the PR did in November. Try again.
icon url

hemopure36

01/07/20 11:28 AM

#18516 RE: eskay1954 #18510

Frankly, if they can put forward a viable breakthrough device application, as I mentioned in an earlier post today, I wouldn't care if they canceled Refresh 2 altogether. It would save much time and money.